𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Intermittent high-dose melphalan/prednisone vs continuous low-dose melphalan treatment in multiple myeloma

✍ Scribed by Åhre, A.; Björkholm, M.; Mellstedt, H.; Holm, G.; Brenning, G.; Engstedt, L.; Gahrton, G.; Hällen, J.; Johansson, B.; Johansson, S.G.O.; Karnström, L.; Killander, A.; Lerner, R.; Lockner, D.; Lönnqvist, B.; Simonsson, B.; Stalfelt, A.-M.; Ternstedt, B.; Wadman, B.

Book ID
122456353
Publisher
Elsevier Science
Year
1983
Weight
744 KB
Volume
19
Category
Article
ISSN
0277-5379

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The use of low-dose prednisone and melph
The use of low-dose prednisone and melphalan in the treatment of poor-risk patients with multiple myeloma
✍ Cuttner, Janet ;Wasserman, L. R. ;Martz, Georg ;Sonntag, Roland W. ;Kyle, Robert 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 416 KB

## Abstract A study was designed to evaluate the effectiveness of prednisone therapy in poor‐risk patients with multiple myeloma. Patients were treated with melphalan alone or in combination with prednisone at doses of either 0.6 mg/kg or 0.3 mg/ kg. The group of patients receiving melphalan and pr